Mehra MR - Search Results

1

Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.

Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M. Mehra MR, et al. J Heart Lung Transplant. 2006 Sep;25(9):1024-42. doi: 10.1016/j.healun.2006.06.008. J Heart Lung Transplant. 2006. PMID: 16962464 No abstract available.

2

Vibrio vulnificus sepsis in solid organ transplantation: a medical nemesis.

Ali A, Mehra MR, Stapleton DD, Kemmerly SA, Ramireddy K, Smart FW, Augustine S, Ventura HO. Ali A, et al. Among authors: mehra mr. J Heart Lung Transplant. 1995 May-Jun;14(3):598-600. J Heart Lung Transplant. 1995. PMID: 7654744

3

Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock.

Malik FS, Mehra MR, Uber PA, Park MH, Scott RL, Van Meter CH. Malik FS, et al. Among authors: mehra mr. J Card Fail. 1999 Mar;5(1):31-7. doi: 10.1016/s1071-9164(99)90022-2. J Card Fail. 1999. PMID: 10194658

4

Cardiac allograft valvulopathy: a case of donor-anorexigen-induced valvular disease.

Prasad A, Mehra M, Park M, Scott R, Uber PA, McFadden PM. Prasad A, et al. Ann Thorac Surg. 1999 Nov;68(5):1840-1. doi: 10.1016/s0003-4975(99)00751-1. Ann Thorac Surg. 1999. PMID: 10585071

5

Crossing the vasculopathy bridge from morphology to therapy: a single center experience.

Mehra MR. Mehra MR. J Heart Lung Transplant. 2000 Jun;19(6):522-8. doi: 10.1016/s1053-2498(00)00116-9. J Heart Lung Transplant. 2000. PMID: 10867331 Review. No abstract available.

6

Long-term outcome of cardiac allograft vasculopathy treated by transmyocardial laser revascularization: early rewards, late losses.

Mehra MR, Uber PA, Prasad AK, Park MH, Scott RL, McFadden PM, Van Meter CH. Mehra MR, et al. J Heart Lung Transplant. 2000 Aug;19(8):801-4. doi: 10.1016/s1053-2498(00)00139-x. J Heart Lung Transplant. 2000. PMID: 10967275

7

Insights into ventricular repolarization abnormalities in cardiac allograft vasculopathy.

Ali A, Mehra MR, Malik FS, Uber PA, Ventura HO. Ali A, et al. Among authors: mehra mr. Am J Cardiol. 2001 Feb 1;87(3):367-8, A10. doi: 10.1016/s0002-9149(00)01381-3. Am J Cardiol. 2001. PMID: 11165983

8

Does hyperuricemia predict adverse clinical outcome while awaiting heart transplantation?

Uber PA, Mehra MR, Park MH, Ventura H, Scott RL. Uber PA, et al. Among authors: mehra mr. J Heart Lung Transplant. 2001 Feb;20(2):164-165. doi: 10.1016/s1053-2498(00)00300-4. J Heart Lung Transplant. 2001. PMID: 11250249 No abstract available.

9

Does HDL-cholesterol level predict clinical outcome in advanced heart failure?

Mehra MR, Uber PA, Park MH, Scott RL, Milani RV. Mehra MR, et al. J Heart Lung Transplant. 2001 Feb;20(2):165. doi: 10.1016/s1053-2498(00)00301-6. J Heart Lung Transplant. 2001. PMID: 11250251 No abstract available.

10

The differential metabolic impact of tacrolimus and cyclosporine immunosuppression in black heart transplant recipients: hyperlipidemia, hypertension and hyperglycemia.

Uber PA, Mehra MR, Vivekananthan N, Scott RL, Park MH. Uber PA, et al. Among authors: mehra mr. J Heart Lung Transplant. 2001 Feb;20(2):192. doi: 10.1016/s1053-2498(00)00401-0. J Heart Lung Transplant. 2001. PMID: 11250329 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters